CD80 and cancer: Not only that, our results also reveal a positive correlation between LAPTM4A and multiple immune checkpoint (ICP) gene expressions, including the well-known CD274, PDCD1 [72], and CD80 [73], which tend to suppress effector T cells to promote cancer development [74].